title: Emphasizing the burden of proof: The American College of Cardiology 2008 Expert Panel Comments on the ENHANCE Trial.
authors.affiliation: Department of Medicine, Yale University School of Medicine, Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, Conn., USA. harlan.krumholz@yale.edu
authors.forename: Harlan M
authors.initials: HM
authors.lastname: Krumholz
mesh_terms: D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D050197:Atherosclerosis / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D001384:Azetidines / Q000627:therapeutic use*; D015415:Biomarkers / Q000378:metabolism; D002309:Cardiology; D002339:Carotid Arteries / Q000187:drug effects / Q000473:pathology; D026661:Clinical Trials Data Monitoring Committees; D002986:Clinical Trials as Topic; D019317:Evidence-Based Medicine; D005104:Expert Testimony; D000069438:Ezetimibe; D006801:Humans; D006937:Hypercholesterolemia / Q000517:prevention & control; D008077:Lipoproteins, LDL / Q000378:metabolism; D019821:Simvastatin / Q000627:therapeutic use*
chemical_list: D000924:Anticholesteremic Agents; D001384:Azetidines; D015415:Biomarkers; D008077:Lipoproteins, LDL; D019821:Simvastatin; D000069438:Ezetimibe